Company Filing History:
Years Active: 2017-2019
Title: Mona Wilcke: Innovator in Pharmaceutical Compounds
Introduction
Mona Wilcke is a prominent inventor based in Stockholm, Sweden. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for treating conditions associated with NADPH oxidase. With a total of 3 patents to her name, her work is paving the way for advancements in medical treatments.
Latest Patents
Mona's latest patents include innovative compounds designed for therapeutic use. One notable patent involves a compound of formula (I) or a pharmaceutically acceptable salt thereof, aimed at treating conditions related to nicotinamide adenine dinucleotide phosphate oxidase. Another significant compound she developed is N-(3,4-dimethylphenyl)-6-((4-(p-tolyl)piperazin-1-yl)methyl)-1,3,5-triazine-2,4-diamine, which is also intended for similar therapeutic applications. These compounds are crucial in addressing disorders linked to NADPH oxidase activity.
Career Highlights
Mona Wilcke is currently associated with Glucox Biotech AB, where she continues to innovate and contribute to the pharmaceutical industry. Her expertise and dedication have positioned her as a key player in her field, driving forward research and development efforts.
Collaborations
Mona collaborates with esteemed colleagues such as Erik Walum and Per Wikström, enhancing her research through teamwork and shared expertise.
Conclusion
Mona Wilcke's contributions to pharmaceutical innovations are noteworthy, and her ongoing work promises to impact the treatment of various medical conditions significantly. Her dedication to research and collaboration exemplifies the spirit of innovation in the pharmaceutical industry.